万维书刊网微信二维码

扫微信,关注编辑QQ!

您的位置:万维书刊网 >>sci/e期刊大全 >>医药卫生1>>胃肠肝病学

GASTROENTEROLOGY《胃肠病学》 (官网投稿)

简介
  • 期刊简称GASTROENTEROLOGY
  • 参考译名《胃肠病学》
  • 核心类别 SCIE(2023版), 高质量科技期刊(T1), 外文期刊,
  • IF影响因子
  • 自引率4.20%
  • 主要研究方向医学-GASTROENTEROLOGY & HEPATOLOGY 胃肠肝病学

主要研究方向:

等待设置主要研究方向
医学-GASTROENTEROLOGY & HEPATOLOGY 胃肠肝病学

GASTROENTEROLOGY《胃肠病学》(一年14期). Gastroenterology is the most prominent journal in the field of gastrointestinal disease. As the official jour...[显示全部]
征稿信息

万维提示:

1、投稿方式:在线投稿。

2、期刊网址:https://www.gastrojournal.org/

https://www.journals.elsevier.com/gastroenterology/

3、投稿网址:

https://www.editorialmanager.com/gastro/

4、官网邮箱:gastro@gastro.org(编辑部)

5、官网电话:(301) 941-2615(编辑部)

6、期刊刊期:一年出版14期。

2021527日星期四

                             

 

投稿须知【官网信息】

 

Author Information

Please address all inquiries to:

Gastroenterology Editorial Office

American Gastroenterological Association

4930 Del Ray Avenue

Bethesda, MD 20814-3015

Phone: (301) 941-2615

Fax: (301) 654-1140

gastro@gastro.org

Gastroenterology publishes clinical and basic studies of all aspects of the digestive system, including the liver and pancreas, as well as nutrition. The types of articles Gastroenterology publishes include original papers, review articles, and special category manuscripts. Manuscripts must be prepared in accordance with the "Uniform Requirements for Manuscripts Submitted to Biomedical Journals" developed by the International Committee of Medical Journal Editors (http://www.icmje.org). Gastroenterologyis a member of the Committee on Publication Ethics (COPE) (http://www.publicationethics.org).

Gastroenterology strongly encourages the submission of papers on a breadth of clinical topics in gastroenterology, hepatology, endoscopy, randomized controlled trials (phases II-IV but typically not phase I), high-quality observational studies, and novel case series.

Gastroenterology is interested in all aspects of clinical trials including treatment, prevention, diagnosis, screening, and quality of life. High-quality meta-analyses are also welcome. Publication priority will be determined by factors such as novelty, impact upon clinical practice, strength of the experimental design, and mechanistic insight.

Gastroenterology is interested in all aspects of high impact translational and basic studies that would be of interest to our broad readership. These aspects include defining a critical physiologic or disease process/pathway, or mechanism for disease progression or protection; identifying a genetic cause, modifier, or association with disease; describing a novel experimental disease model; characterizing a novel GI-related mechanism of drug action; preclinical studies that describe a potential novel therapy, diagnostic, or prognostic marker or tool that is related a disease.

Gastroenterology has a total circulation of approximately 17,000-about 12,000 in the United States and 5,000 in other countries. 80% of subscribers are AGA members. In the United States, about 75% of subscribers are physicians, and about 25% of subscriptions go to residents, medical schools, and libraries. About 68% of the papers published originate overseas.

Gastroenterology is abstracted and indexed in Biological Abstracts, CABS, Chemical Abstracts, Current Contents, Excerpta Medica, Index Medicus, Nutrition Abstracts, and Science Citation Index.

Gastroenterology is the highest-ranking journal for original GI, hepatology and nutrition research in the 2018 Journal Citation Reports, published by Clarivate Analytics, and has an Impact Factor of 19.809. Its immediacy index, which is a measure of how topical and urgent work published in Gastroenterology is, is 4.003, one of the highest in the field. On average, authors receive decisions on their manuscripts within three weeks.

Information about Article Types

Submission Checklist

Preprint Server Policy

Data Transparency Policy

Graphical Abstracts

Manuscript Processing and Review

Publication

Ethical Standards

Conflict of Interest Policy

Plagiarism, Duplicate Submission/Publication Policy

Image Manipulation Policy

Open Access Policies

Continuing Medical Education/Maintenance of Certification

Author Fees

Clinical Trials

Reporting Meta-Analyses of Genetic Studies

Distribution of Material Described in Published Papers

INFORMATION ABOUT ARTICLE TYPES

All manuscripts must be submitted via http://www.editorialmanager.com/gastro

Original Articles

Original Articles are full-length reports of original research. Articles cover topics relevant to clinical, basic, and translational studies in these areas of interest. They may discuss nutrition, immunology, cell biology, molecular biology, morphology, physiology, pathophysiology, epidemiology, imaging, or therapy. Both adult and pediatric problems are included. To be published, the work presented in the manuscript must be original; on occasion, confirmatory studies of timely and important observations will also be acceptable. Submissions must adhere to the following guidelines:

Manuscript: only Microsoft Word documents will be accepted.

Title page: title; authors' names; authors' institutions; corresponding author contact information; conflict of interest statement (for all authors); author contributions to manuscript; statement of whether data, analytic methods, and study materials will or will not be made available to other researchers. If study materials will be made available, specify where they will be made available.

Word count:7,000 words (inclusive of main text; references; table/figure legends).

Approximately 1,000 words of the total count should appear in the "Materials and Methods" section of the manuscript.

Materials and Methods should be placed immediately after the Introduction.

Abstract: 260 words, structured as follows: background and aims; methods; results; conclusion; 4-5 keywords.

Tables/Figures: seven tables (no panels) and/or figures total.

Please submit figures as separate attachments in JPEG, TIFF, EPS, or PDF formats (300 PPI resolution).

The editor reserves the right to publish excessively long tables as online-only material.

References: please list names of authors who share first authorship in bold text. In addition, include the phrase "Author names in bold designate shared co-first authorship" at the end of the references section. Gastroenterology requires authors to cite underlying or relevant datasets in their manuscript by citing them in the text and including a data reference in the Reference List. Data references should include the following elements: author name(s), dataset title, data repository, version (where available), year, and global persistent identifier. Add [dataset] immediately before the reference so we can properly identify it as a data reference. The [dataset] identifier will not appear in your published article.

What You Need to Know: This note will appear as a box on the second page of the published version of each article, containing brief summarizations about your study under the following 4 headings: BACKGROUND AND CONTEXT, NEW FINDINGS, LIMITATIONS, and IMPACT. Please provide 25-30 words (about one sentence) under each of these 4 headings that very briefly and simply summarize your study in relation to each category. These should lack abbreviations and have clear language explaining the importance of your results to clinicians/researchers not familiar with your specialty area

Lay summary: Please prepare a concise "lay summary" of the article's findings. It should be 25-30 words (about one sentence) and very briefly summarize the article's main findings in simple lay terms. You will upload this summary on the Editorial Manager website when you submit your revision. It will appear on the Gastroenterology table of contents if your paper is ultimately accepted and may be used in social media promotions.

Randomized Controlled Trials: Provide CONSORT checklist and patient flowchart as supplemental attachments.

Clinical Trials:

Provide the clinical trial registry website and trial number at the end of the "conclusions" section of the abstract.

Include a statement in the "methods" section of the manuscript affirming that "all authors had access to the study data and reviewed and approved the final manuscript.

Include the clinical trial protocol in English as a supplemental attachment.

Gastroenterologyrequires that clinical trial reports address the authors' intent to share deidentified individual participant data. To that end, authors must include a Data Sharing Statement on the title page under the heading "Data Transparency Statement". The statement should include the following information:

If deidentified individual participant data be shared

Which particular data will be shared

Any additional documents that will be shared

The method through which data will be shared

The timeframe during which data will be accessible

The conditions, if any, required to access to the data

"Deidentified individual participant data are available indefinitely at www.example.org. The study protocol, analytic code?[etc.] are also available at the same website."

"Deidentified individual participant data that underlie the reported results will be made available 3 months after publication for a period of 5 years after the publication date at www.example.org. The study protocol is included as a data supplement available with the online version of this article."

"Individual participant data will not be shared."

Registration

In accordance with the guidelines set forth by ICMJE, authors of manuscripts involving clinical trials must provide full registration of their trial(s). A clinical trial is defined as any research project that prospectively assigns human subjects to intervention and comparison groups to study the cause-and-effect relationship between a medical intervention and a health outcome. The trial must have at least one prospectively assigned concurrent control or comparison group in order to trigger the requirement for registration. Appropriate online registries include https://clinicaltrials.gov/, http://www.isrctn.com/, http://www.umin.ac.jp/ctr/index.htm, http://www.anzctr.org.au/,http://www.trialregister.nl/trialreg/index.asp, or any primary registers that participate in the World Health Organization's International Clinical Trial Platform.

Brief Communications

Brief Communications are concise, meritorious scientific reports of novel original research. Topics of reports may include, but are not limited to, identification of the genetic basis of a disease, a description of a unique case series, novel techniques, new animal models of human disease, and mechanistic insights. Submissions to Brief Communications must adhere to the following guidelines:

Manuscript: only Microsoft Word documents will be accepted.

Title page: title; authors' names; authors' institutions; corresponding author contact information; conflict of interest statement (for all authors); author contributions to manuscript; statement if data, analytic methods, and study materials will or will not be made available to other researchers. If study materials will be made available, specify where they will be made available.

Maximum of 6 authors

Word count: Article text must not exceed 1000 words (not including table, figure, or references).

Brief Communications must include these elements in this order: Introduction, Methods, Results, and Discussion, and all article titles should be declarative.

If needed, a brief communication may include up to an additional 1000 words of supplemental text for describing methods. The text cannot be used to provide additional results or discussion.

Abstract: No abstract.

Tables/Figures: May include up to 1 table or figure.

Please submit figures as separate attachments in JPEG, TIFF, EPS, or PDF formats (300 PPI resolution).

If needed, a brief communication may include 1-2 additional figures or tables (maximum of two total figures + tables) as supplementary material, for describing results.

References: Limited to 8

Format: Jones RS, et al. Gastroenterology 2011; 2: 373 -380 (only the first author is listed, unless manuscripts with joint first authors are cited, and article title is not included).

In the references, please list names of authors who share first authorship in bold text. In addition, include the phrase "Author names in bold designate shared co-first authorship" at the end of the references section. Gastroenterology requires authors to cite underlying or relevant datasets in their manuscript by citing them in the text and including a data reference in the Reference List. Data references should include the following elements: author name(s), dataset title, data repository, version (where available), year, and global persistent identifier. Add [dataset] immediately before the reference so we can properly identify it as a data reference. The [dataset] identifier will not appear in your published article.

These reports are not the same as a Letter to the Editor and must not duplicate other material published or submitted for publication.

In the references, please list names of authors who share first authorship in bold text. In addition, include the phrase "Author names in bold designate shared co-first authorship" at the end of the references section

Clinical Challenges and Images in GI

This article type presents a striking image that is meant to test and inform readers. The article is presented as an unknown with the diagnosis hinging on the correct interpretation and integration of the image and clinical data. The answer is presented on a separate page of the journal. The section is intended to illustrate and teach important medical points. Submissions must adhere to the following guidelines:

Manuscript: only Microsoft Word documents will be accepted.

Title Page: title (cannot reveal diagnosis); authors' names (limit of three); authors' institutions; corresponding author contact information; conflict of interest statement (for all authors); 3-4 keywords

Word Count: Question and Answer format (one page each).

Keywords: Include 3-4 keywords on the title page.

Abstract: No abstract.

Tables/Figures: no limit.

Images can be either clinical, pathologic (gross or microscopic), endoscopic, or radiographic. They must be of high quality (300 PPI resolution) and illustrate the diagnosis well.

Please submit figures as separate attachments in JPEG, TIFF, EPS, or PDF formats.

Do not place figure labels directly on the images.

All necessary information pertaining to figures must be included in the text (i.e., no figure legends).

References: limited to three

Correspondence

Letters to the Editor allow the opportunity to offer novel perspectives and opinions on full-length original research articles and brief communications published in Gastroenterology. Letters must be submitted for consideration by the end of the month in which the corresponding article was published in print (e.g., a response to an article in the July issue should be submitted by the end of July). Letters accepted for publication are collated at the end of the submission period and sent to the authors of the original article for a response; the authors are given two weeks to reply. A decision will then be made whether to publish the letter with or without its reply. Submissions must adhere to the following guidelines:

Manuscript: only Microsoft Word documents will be accepted.

Title Page: title; authors' names (limit of three); authors' institutions; corresponding author contact information; conflict of interest statement (for all authors).

Word Count: 750 (inclusive of main text and table/figure legends).

Abstract: not required.

Tables/Figures: Not permitted.

References: Limited to 8.

Format: Jones RS, et al. Gastroenterology 2011; 2: 373 -380 (only the first author is listed, unless manuscripts with joint first authors are cited, and article title is not included).

Gastroenterology in Motion

This article type contains two parts: (1) video and narration; (2) published text with relevant figures/tables. Submissions must adhere to the following guidelines:

Manuscript: only Microsoft Word documents will be accepted.

Title page: title; authors' names; authors' institutions; corresponding author contact information; conflict of interest statement (for all authors); author contributions to manuscript.

Word Count: 1,000 (inclusive of main text, references, and table/figure legends) and must include the following sections:

Introduction (one paragraph without a header).

Description of technology (one paragraph).

Video description (up to two paragraphs).

Take home message (implications/significance of video demonstration [one to 8 sentences]).

Abstract: not required.

References: Limited to 8.

Format: Jones RS, et al. Gastroenterology 2011; 2: 373 -380 (only the first author is listed, unless manuscripts with joint first authors are cited, and article title is not included).

Tables/Figures:

A combination of up to two figures and/or tables in total can be included with the submission. The figures must be submitted as separate attachments and tables cannot include panels.

Please submit figures as separate attachments in JPEG, TIFF, EPS, or PDF formats. Figures must have a resolution of 300 PPI or greater.

Figures must be accompanied by concise figure legends.

Video Guidelines

All videos must be of the highest quality possible. Any editing of the video is the responsibility of the author(s).

No editing of the original data in individual frames or alteration of the original speed of the video can be made unless clearly stated.

Transitions should be selected in a consistent and simple pattern. Dramatic transitions are discouraged as they tend to distract the viewers from the main contents of the video.

Allow adequate pauses for the viewers to properly take in the information presented. A typical pause should be 4 -5 seconds long.

Acceptable video file formats are: MPEG (.mpg), Quicktime (.mov), or Microsoft (.avi).

Maximum video length is 5 minutes each. Maximum file size/video is 160 MB.

No more than 2 videos per submission

Concise legends must accompany each video in the text file.

Narration can be included with the video. If you elect to include narration, be sure that all audio is at an appropriate level to be understood using computer speakers at mid-level volume.

Patients should not be identifiable, or their pictures must be accompanied by written permission to use the video.

Histology and/or radiology can be included for teaching purposes.

There are no submission fees or page charges.

Copyright: The AGA Institute holds the copyright to all accepted videos and their accompanying text. To reuse the video or text in any form, permission must first be obtained from Gastroenterology's publisher, Elsevier.

Protected Health Information (PHI) must be removed from manuscripts, figures, and videos prior to submission. Any Gastroenterology in Motion submission found to contain PHI will be summarily rejected without opportunity for resubmission.

Practical Teaching Cases

Practical Teaching Cases showcase common clinical scenarios that are part of the knowledge base of GI. The section serves the growing need for standardized, high-quality educational activities that are easily accessible and useful to Gastroenterology's readership. Information regarding the specific patient (in terms of follow-up and response to therapy) must be given as appropriate. Submissions must adhere to the following guidelines:

Manuscript: only Microsoft Word documents will be accepted.

Title Page: title (cannot reveal diagnosis); authors' names (limit of three); authors' institutions; corresponding author contact information; conflict of interest statement (for all authors); 3-4 keywords

Word Count: one-page case description; a structured multiple choice question (4 possible answers, all plausible); one page discussion of correct answer.

Keywords: Include 3-4 keywords on the title page.

Abstract: No abstract.

Tables/Figures: no limit.

Images can be either clinical, pathologic (gross or microscopic), endoscopic, or radiographic. They must be of high quality (300 PPI resolution) and illustrate the diagnosis well.

In addition to images, some cases may lend themselves to the presentation of serial lab data in a figure or table format using standard Gastroenterology formatting.

Please submit figures as separate attachments in JPEG, TIFF, EPS, or PDF formats.

Do not place figure labels directly on the images.

All necessary information pertaining to figures must be included in the text (i.e., no figure legends).

References: limited to three

Meeting Summaries

This section includes brief reports of symposia, conferences, and meetings in digestive disease research. They include critical commentary, connections among the presentations, and consensus, if any, that emerged from the meeting. The editors encourage authors of potential meeting summaries to propose submissions for this section in advance of scheduled meetings. Summaries must be submitted within two months after a meeting.

Title Page: title; authors' names (limit of three); authors' institutions; corresponding author contact information; conflict of interest statement (for all authors).

Word Count: 2,400 (inclusive of main text and table/figure legends).

Tables/Figures: Up to two

References: Up to 25

Mentoring, Education, and Training Corner

This section focuses on the education, development, and support of young learners and proteges in the field of digestive disease. Expert guest authors will provide reviews on a wide array of topics including career opportunities, steps for success, gender and ethnic diversity, training updates, and balancing home and work life. The material presented in this section will be organized by overarching themes. Submissions are by invitation only, but email inquiries (gastro@gastro.org) by prospective authors will be considered.

Editorials

Editorials express opinions on current topics of interest or provide comments on papers published elsewhere in the same issue. Submissions are by invitation only.

Reviews in Basic and Clinical Gastroenterology and Hepatology

Brief and Full Reviews are solicited by the board of editors and no unsolicited reviews will be considered.

Covering the Cover

This section provides a general preview of two clinical articles and two basic articles that appear in each issue and are of particular importance to our readership. As it is written by the section editors, no unsolicited submissions will be considered.

Selected Summaries

Selected Summaries are concise, expert overviews of articles recently published in other journals, books, and digital media that are of potential interest to our readership. Summaries are primarily written by a regular staff of contributors selected by the Section Editors.

Clinical Practice Updates

This section provides authoritative, balanced, and comprehensive narrative reviews and rapid commentaries derived from the following sources: a) proposed guidelines which do not meet criteria for guideline grading; b) topics generated by the Clinical Practice Updates Committee (CPUC), Gastroenterology editors, and other AGA committees and members; c) summaries of important symposia (e.g., Freston Conference). As topics and authors are selected by CPUC, the AGA Institute Governing Board, and the Clinical Guidelines Committee, submissions are by invitation only.

Potential subjects for these articles will derive from several sources in coordination with the AGA Institute Clinical Guidelines Committee. First, important topics that are initially proposed for an AGA guideline but do not meet rigid criteria for guideline grading will be sent to CPUC for review and consideration. Second, ideas for topics will be generated by CPUC and Gastroenterology editors as well as other AGA committees and members. Third, summaries of important symposia (e.g., Freston Conference) will be included. Topics can be presented in the form of a comprehensive, narrative review or-for particularly timely issues in gastroenterology, hepatology, and health care in general-as a rapid commentary.

All prospective topics and selected authors will be approved by CPUC with guidance from the AGA Institute Governing Board. At least two authors, from different institutions, who are recognized authorities will be invited to write an article. It is anticipated that the authors will often have differing opinions to help ensure balance and achieve consensus. A member of CPUC with expertise in the field will guide the writing to ensure the highest quality and greatest balance in the final product. Once an article is written, it will be submitted for evaluation by Gastroenterology editors, who will decide whether to accept the paper or send it for further review prior to acceptance. With seasoned and motivated authors and the guidance of CPUC, these outstanding reviews will be published in a timely manner and provide Gastroenterology readers the most up-to-date and scholarly information across the spectrum of gastroenterology, hepatology, and nutrition.

Commentaries

Commentaries express perspectives or provide information on current topics of interest in the field of GI and hepatology. They may be solicited or unsolicited.

Title Page: title; authors' names (limit of three); authors' institutions; corresponding author contact information; conflict of interest statement (for all authors).

Abstract: no abstract

Word Count: 2,400 (inclusive of main text and table/figure legends).

Tables/Figures: Up to two

References: Up to 25

SUBMISSION CHECKLIST

** All manuscripts must be submitted via http://www.editorialmanager.com/gastro**

All manuscripts should be double-spaced Microsoft Word documents and contain the following sections in the order given below:

Cover Letter

Gastroenterology strongly encourages authors to provide a concise introductory statement describing their manuscript and any relevant contextual information. Please note that the Cover Letter should not serve as the Title Page of your manuscript document. Additionally, authors should suggest two to five reviewers (including email addresses and phone number) as well as the associate editor they believe is best qualified to review the paper. Authors may also list non-preferred associate editors or reviewers, but the ultimate decision is at the sole discretion of the editor-in-chief and associate editor, respectively. Please be sure to state the reasons for any potential deviations from standard format and clarify any potential conflicts related to the exclusive nature of the publication. The Cover Letter should also categorize the manuscript into one of the following categories:

Clinical:

Alimentary Tract; Liver; Pancreas; or Biliary

Basic and Translational

Alimentary Tract; Liver; Pancreas; or Biliary

Title Page

A Title Page must be included as the first page of the manuscript document. It should also contain the following sections in the order given below:

Title: include animal species; use no abbreviations; limited to 120 characters (with spaces).

Short Title: limited to 45 characters (with spaces).

Author(s): list full names of all authors; their positions and institutions; location of department and institution where the work was performed.

Grant support: list grant support and other assistance.

Abbreviations: list abbreviations (in alphabetical order) not mentioned in the Style Guide following the Instructions to Authors. (Note: In general, the use of abbreviations is discouraged).

Correspondence: provide contact information (i.e., name, physical address, email address, telephone, and fax numbers) of the corresponding author.

Disclosures: list any potential conflicts (financial, professional, or personal) relevant to the manuscript. If an author has nothing to disclose, this must be stated.

Transcript Profiling: list accession number of repository for expression microarray data.

Writing Assistance: list names and funding source for individuals who provided writing assistance.

Author Contributions: Upon submission of a manuscript via Editorial Manager, the corresponding author of the manuscript must select a role(s) for each author from a pre-populated list of authorship roles from the CRediT Taxonomy (https://www.casrai.org/credit.html), which is a widely accepted and used high-level taxonomy that represent the roles typically played by contributors to scientific scholarly output. Detailed instructions can be found at editorialmanager.com/gastro when submitting a manuscript.

Data Transparency Statement: statement of whether data, analytic methods, and study materials will or will not be made available to other researchers. If study materials will be made available, specify where they will be made available.

……

更所详情:

https://www.gastrojournal.org/content/authorinfo


  • 万维QQ投稿交流群    招募志愿者

    版权所有 Copyright@2009-2015豫ICP证合字09037080号

     纯自助论文投稿平台    E-mail:eshukan@163.com


投稿问答最小化  关闭